Experimental sensory neuropathy induced by sensitization with ganglioside GD1b

Annals of Neurology

Volumn 39, Issue 4, 1996, Pages 424-431

  Kusunoki, S ^a   Shimizu, J ^a   Chiba, A ^a   Ugawa, Y ^a   Hitoshi, S ^a   Kanazawa, I ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; GANGLIOSIDE GD 1B; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; AUTOIMMUNITY; CONTROLLED STUDY; DORSAL ROOT; IMMUNIZATION; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCIATIC NERVE; SENSITIZATION; SENSORY NEUROPATHY; SPINAL CORD ATROPHY; SPINAL GANGLION;

EID: 0029932201     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390404     Document Type: Article

References (29)

1. 1 Iiyas AA Willison HJ Quarles RH et al Serum antibodies to gangliosides in Guillain‐Barre syndrome. Ann Neurol 1988 ; 23: 440–447
2. 2 Yuki N. Yoshino H, Sato S Miyatake T. Acute axonal polyneuropathy associated with anti‐GM1 antibodies following Campylobacter enteritis. Neurology 1990 ; 40: 1900–1902
3. 3 Walsh FS, Cronin M Koblar S, et al. Association between glycoconjugare antibodies and Campylobacter infection in patients with Guillain‐Barré syndrome. J Neuroimmunol 1991 ; 34: 43–51
4. 4 Ilyas AA, Mithen FA, Dalakas MC, et al. Antibodies to acidic glycolipids in Guillain‐Barre syndrome and chronic inflamm‐ tory demyelinating polyneuropathy. J Neurol Sci 1992 ; 107: 111–121
5. 5 Chiba A, Kusunoki S, Obata H et al. Serum anti‐GQlb IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barré syndrome: clinical and inimunohistochemical studies. Neurology 1993 ; 43: 1911–1917
6. 6 Kusunoki S, Chiba A Kon K, et al. N‐Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐ Barre syndrome. Ann Neurol 1994 ; 35: 570–576
7. 7 Hartung HI. Pollard JD, Harvey GK, Toyka KV Immunopathogenesis and treatment of the Guillain‐Barré syndrome‐part I. Muscle Nerve 1995: 18 137–153
8. 8 Kusunoki S. Chiba A Hitoshi S et al. Anti‐Gal‐C antibody in auroimmune neuropathies subsequent to mycoplasma infec‐tion. Muscle Nerve 1995 ; 18: 409–413
9. 9 Pestronk A. Motor neuropathies motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve 1991 ; 14: 927–936
10. 10 Ilyas AA, Quarks RH, Dalakas MC, et al. Monoclonal IgM in a patient with paraproteinemic neuropathy binds to ganglio‐ sides containing disialosyl groups. Ann Neurol 1985: 18: 655–659
11. 11 Obi T, Kusunoki S Takatsu M, et al. IgM M‐protein in a patient with sensory‐dominant neuropathy binds preferentially to polysialogangliosides. Acta Neurol Scand 1992 ; 86: 215–218
12. 12 Daune GC, Farrer RG, Dalakas MC. Quarles RH. Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside. Ann Neurol 1992 ; 31: 683–685
13. 13 Willison HJ, Paterson G Veitch J et al. Peripheral neuropathy associated with monoclonal IgM anti‐Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry 1993: 56: 1178–1183
14. 14 Sadiq SA. Thomas FP, Kilidireas K et al. The spectrum of neurologic disease associated with anti‐GMI antibodies. Neu‐ rology 1990 ; 40: 1067–1072
15. 15 Ando S. Gangliosides in the nervous system. Neurochem Int 1983 ; 5: 507–537
16. 16 Kusunoki S, Chiba A Tai T, Kanazawa I Localization of GM1 and GD1b antigens in the human peripheral nervous system. Muscle Nerve 1993 ; 16: 752–756
17. 17 Ozawa H, Kotani M Kawashiina I, Tai T Generation of one set of monoclonal antibodies specific for b‐pathway ganglio‐ series gangliosides. Biochim Biophys Acta 1992: 1123: 184–190
18. 18 Kohriyama T, Ariga T Yu RK. Preparation and characterization of antibodies against a sulfated glucuronic acid‐containing glycosphingolipid. J Neurochem 1988 ; 51: 869–877
19. 19 Kusunoki S Shimizu T, Matsumura K et al. Motor dominant neuropathy and IgM paraproteinemia: rhe IgM M‐protein binds to specific gangliosides. J Neuroimmunol 1989 ; 21 177–181
20. 20 Hirabayashi Y, Suzuki T Suzuki Y, et al. A new method for purification of anti‐glycosphingolipid antibody. J Biochem (Tokyo) 1983 ; 94: 327–330
21. 21 Chiba A, Kusunoki S Shimizu T, Kanazawa I Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992 ; 31: 677–679
22. 22 Saida T, Saida T, Dorfman SH, et al. Experimental allergic neuritis induced by sensitization with galactocerebroside. Science 1979 ; 204: 1103–1106
23. 23 Santoro M, Uncini A Corbo M, et al. Experimental conduction block induced by serum from a patient with anti‐GMl antibodies. Ann Neurol 1992 ; 31: 385–390
24. 24 Arasaki K, Kusunoki S Kudo N. Kanazawa I Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 1993 ; 16: 587–593
25. 25 Roberts M. Willison HJ, Vincent A Newsom‐Davis J Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol 1995 ; 38: 111–118
26. 26 Nagai Y. Momoi T, Saito M et al. Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci Lett 1976 ; 2: 107–111
27. 27 Thomas FP, Trojaborg W Nagy C, et al. Experimental autoimmune neuropathy with anti‐GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol 1991 ; 82: 378–383
28. 28 Ponzin D, Menegus AM, Kirschner G et al. Effects of gangliosides on the expression of autoimmune demyelination in the peripheral nervous system. Ann Neurol 1991 ; 30: 678–685
29. 29 Wietholter H, Schahet M Stevens A, et al. Influence of gangliosides on experimental allergic neuritis. J Neuroimmunol 1992 ; 38: 221–228